FRC
FRC Logo
CommunityMarkets
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileThermo Fisher Scientific Inc.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
TMO
Thermo Fisher Scientific Inc. Stock AnalysisComprehensive stock analysis for Thermo Fisher Scientific Inc. (TMO) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisTMO
TMO
Thermo Fisher Scientific Inc.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
TMO
  1. Home
  2. Stocks
  3. Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Inc.

🇺🇸TMO•NYSE

Thermo Fisher Scientific Inc.

🇺🇸TMO•NYSE
Market cap
$256.15B
Sentiment

Your view on TMO

Mkt Cap
$256.15B
Sentiment
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Thermo Fisher Scientific Inc.

Industry
Medical - Diagnostics & Research
Sector
Healthcare
CEO
Marc N. Casper
Headquarters
168 Third Avenue, Waltham, MA, US
Industry
Medical - Diagnostics & Research
Sector
Healthcare
CEO
Marc N. Casper
Headquarters
168 Third Avenue, Waltham, MA, US
Description

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally.

The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.

Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories.

The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products.

Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research.

It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD.

Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.

Financial Data

Stock Data

Price chart, volume, and trading data.

FRC Fair Value Algorithm

What the FRC Fair Value algorithm says it is worth vs. the current price — FRC's own, on every stock.

About this section

Fair value for Thermo Fisher Scientific Inc. from FRC's valuation model, read against the market price. TMO last traded at $691.33, 36.4× trailing earnings — the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for Thermo Fisher Scientific Inc.. Starting points for Thermo Fisher Scientific Inc.: P/E 36.4, EPS $19.14, beta 0.84 — an Medical - Diagnostics & Research name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

About this section

Dividend history, yield and payout sustainability for Thermo Fisher Scientific Inc.. Thermo Fisher Scientific Inc. paid $1.84 per share over the last year — a 0.3% yield at the current $691.33 price. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for Thermo Fisher Scientific Inc.. Trailing twelve-month EPS for Thermo Fisher Scientific Inc. stands at $19.14. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Wall Street Analyst Estimates

Analysts' price targets, ratings, and revenue and EPS estimates.

Third partyAs of Nov 18, 2026 · USD

Price targets, ratings and estimates published by outside analysts. Not FRC research, not a recommendation, and not the FRC Fair Value: that is FRC's proprietary model, built on the cash a company generates.

Current price

—

live quote

Analysts' target

$707.10

average of 20 firms, last 12 months

 

$707.10

Low $520.00

Median $735.00

High $810.00

 

Analyst Ratings

Buy13 firms, last 12 months
  • Strong Buy0
  • Buy10
  • Hold3
  • Sell0
  • Strong Sell0

Earnings Estimate

EPSCurrent QtrDec 2026Next QtrMar 2027Current YearFY Dec 2026Next YearFY Dec 2027
Avg. estimate$7.13$6.06$25.29$27.75
Low estimate$7.01$5.73$25.18$26.96
High estimate$7.26$6.23$25.43$29.24
No. of analysts1591616
Year-ago EPS$6.57$5.44$17.74—
Growth+8.5%+11.4%+42.6%—

Revenue Estimate

RevenueCurrent QtrDec 2026Next QtrMar 2027Current YearFY Dec 2026Next YearFY Dec 2027
Avg. estimate$12.84B$11.74B$48.00B$50.57B
Low estimate$12.69B$11.63B$47.83B$50.32B
High estimate$13.07B$11.82B$48.18B$51.09B
No. of analysts1382019
Year-ago revenue$12.21B$11.01B$44.56B—
Growth+5.1%+6.7%+7.7%—
Recent analyst actions15 rating and price-target changes, latest Oct 30, 2026 — with the analyst, firm and source

Source: Wall Street analysts' published price targets, ratings and estimates, compiled by Financial Modeling Prep from StreetInsider, Benzinga, Pulse 2.0, MarketWatch; as of Nov 18, 2026. Not FRC research or a recommendation.

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for Thermo Fisher Scientific Inc.. Thermo Fisher Scientific Inc. has reported as a listed company since 1980. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold TMO18 companies · 8 funds
Compare TMO with its peers, side by sidePremiumRatios, margins, valuation and leverage of the peers below — one table, one glance.Open Comparable Analysis

Peer companies

Market cap

  • AAgilent Technologies, Inc.Medical - Diagnostics & Research$48.8B
  • BIOBio-Rad Laboratories, Inc.Medical - Devices$9.7B
  • BRKRBruker CorporationMedical - Devices$9.3B
  • DHRDanaher CorporationMedical - Diagnostics & Research$161.9B
  • QGENQiagen N.V.Medical - Diagnostics & Research$10.3B
  • RVTYRevvity, Inc.Medical - Diagnostics & Research$16.6B

More Medical - Diagnostics & Research companies

  • SKHHYSonic Healthcare LimitedOTC$8.2B
  • SLDXStella Diagnostics Inc.OTC$1M
  • SPDESpeedus Corp.OTC$416
  • SZLSFStageZero Life Sciences Ltd.OTC$61,766
  • TDSGFTelo Genomics Corp.OTC$4M
  • TELO.VTelo Genomics Corp.TSXV$4M
  • THOXFBioPorto A/SOTC$74M
  • TMO.NEThermo Fisher Scientific Inc.NEO
  • TOMDFTodos Medical Ltd.OTC$14,081
  • TTOOT2 Biosystems, Inc.OTC$11,218
  • TWSTTwist Bioscience CorporationNASDAQ$6.9B
  • VCYTVeracyte, Inc.NASDAQ$1.9B

ETFs holding Thermo Fisher Scientific Inc.

% of the fund

  • VOOVanguard S&P 500 ETF$1.0T in assets0.39%
  • VTIVanguard Total Stock Market ETF$689.2B in assets0.35%
  • IVViShares Core SP 500 ETF$852.9B in assets0.40%
  • SPYState Street SPDR S&P 500 ETF Trust$818.5B in assets0.40%
  • QLTYGMO U.S. Quality ETF$5.4B in assets4.40%
  • IYHiShares US Healthcare ETF$4.7B in assets3.72%
  • FHLCFIDELITY MSCI HEALTH CARE INDEX ETF$4.0B in assets3.30%
  • IXJiShares Global Healthcare ETF$4.6B in assets2.86%

Largest holders first, then the funds most concentrated in TMO.

Open Comparable Analysis
Ownership & News

Institutional Ownership

Which funds and firms own the stock.

About this section

Which institutions hold Thermo Fisher Scientific Inc., and how their positions are changing. At a $256.15B market value, institutional positions materially move Thermo Fisher Scientific Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.

Insider Trading

Recent buying and selling by company executives.

About this section

Buying and selling by Thermo Fisher Scientific Inc. executives and directors. Shares of Thermo Fisher Scientific Inc. have traded between $385.46 and $610.97 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.

Senate Trading

U.S. Senator disclosures filed under the STOCK Act.

About this section

U.S. Senate disclosures naming Thermo Fisher Scientific Inc.. Thermo Fisher Scientific Inc. is a $256.15B Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely.

House Trading

U.S. Representative disclosures filed under the STOCK Act.

About this section

U.S. House of Representatives disclosures naming Thermo Fisher Scientific Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals.

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for Thermo Fisher Scientific Inc.. Coverage tracks Thermo Fisher Scientific Inc. within Medical - Diagnostics & Research (Healthcare). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

News

Latest Market News